Clinical Trial

Azithromycin for Cerclage Prophylaxis

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The primary goal is to assess the effectiveness in pregnancy prolongation utilizing azithromycin at the time of transvaginal cervical cerclage placement.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-05-20; most recent amendment 2026-07-21.
Trial Details
NCT Number NCT07608562
Lead Sponsor Wake Forest University Health Sciences
Conditions Cervical Insufficiency
Enrollment 80 participants
Start Date 2026-08
Primary Completion 2028-06 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-23